Metraipolis › archive › dc_007287b4fa01

"Efficacy and safety of bimekizumab in moderate-to-severe hidradenitis suppurativa: A systematic review and meta-analysis of RCTs" — Europe PMC PMID:41686586

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41686586
DOI
10.1097/md.0000000000047691
License (as archived)
solo-consultazione
Archived
2026-11-06T08:44:12.227Z
SHA-256 of the archived text
0fb888fdc9be46d5109e96798071c2093c959140a40031c36905d8a3bce1542d
Stable URL of this page
https://metraipolis.com/documento/dc_007287b4fa01

How to cite

"Efficacy and safety of bimekizumab in moderate-to-severe hidradenitis suppurativa: A systematic review and meta-analysis of RCTs" — Europe PMC PMID:41686586 — Europe PMC (en), https://europepmc.org/article/MED/41686586 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_007287b4fa01 (Metraipolis archive dc_007287b4fa01, sha256 0fb888fdc9be46d5109e96798071c2093c959140a40031c36905d8a3bce1542d)
BibTeX
@misc{dc007287b4fa01,
  title = {"Efficacy and safety of bimekizumab in moderate-to-severe hidradenitis suppurativa: A systematic review and meta-analysis of RCTs" — Europe PMC PMID:41686586},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41686586},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_007287b4fa01; sha256 0fb888fdc9be46d5109e96798071c2093c959140a40031c36905d8a3bce1542d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41686586. Agents can read the archived copy with the MCP tool read_document.